Skip to main content
. 2015 Feb 16;21(4):345–353. doi: 10.5761/atcs.oa.14-00262

Fig. 1.

Fig. 1

Overall (OS), cancer-specific (CSS), and recurrence-free (RFS) survival curves for p-stage N2 non-small cell lung cancer patients. (A) OS, (B) CSS, and (C) RFS rates are 46%, 55% and 24%, respectively, from 1990 to 2009.